REPL
Replimune Group Inc
Price:  
8.92 
USD
Volume:  
844,488.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

REPL Relative Valuation

-1221.8%
Upside

As of 2026-01-08, the Relative Valuation of Replimune Group Inc (REPL) is (100.06) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.92 USD, the upside of Replimune Group Inc based on Relative Valuation is -1221.8%.

The range of the Relative Valuation is (74.68) - (103.91) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 18.6x - 26.3x 22.5x
Forward P/E multiples 18.9x - 37.5x 28.2x
Fair Price (74.68) - (103.91) (100.06)
Upside -937.2% - -1264.9% -1221.8%
8.92 USD
Stock Price
(100.06) USD
Fair Price

REPL Relative Valuation - Historical P/E Data

Date P/E
2026-01-02 -2.25
2025-12-31 -2.46
2025-12-30 -2.49
2025-12-29 -2.47
2025-12-26 -2.52
2025-12-24 -2.55
2025-12-23 -2.46
2025-12-22 -2.51
2025-12-19 -2.50
2025-12-18 -2.45
2025-12-17 -2.44
2025-12-16 -2.43
2025-12-15 -2.52
2025-12-12 -2.58
2025-12-11 -2.50
2025-12-10 -2.49
2025-12-09 -2.61
2025-12-08 -2.72
2025-12-05 -2.69
2025-12-04 -2.67
2025-12-03 -2.61
2025-12-02 -2.53
2025-12-01 -2.46
2025-11-28 -2.53
2025-11-26 -2.55
2025-11-25 -2.41
2025-11-24 -2.38
2025-11-21 -2.33
2025-11-20 -2.28
2025-11-19 -2.28
2025-11-18 -2.21
2025-11-17 -2.22
2025-11-14 -2.28
2025-11-13 -2.27
2025-11-12 -2.29
2025-11-11 -2.31
2025-11-10 -2.20
2025-11-07 -2.10
2025-11-06 -2.15
2025-11-05 -2.17
2025-11-04 -2.27
2025-11-03 -2.36
2025-10-31 -2.46
2025-10-30 -2.59
2025-10-29 -2.58
2025-10-28 -2.64
2025-10-27 -2.36
2025-10-24 -2.23
2025-10-23 -2.13
2025-10-22 -2.10